Since TGF-β1 has been shown to be capable of controlling the proinflammatory effects of FasL overexpression (Chen et al, 1998), we sought to determine if expression of TGF-β1 might account for the lack of neutrophil recruitment in FasL-positive colon cancers. Here, FASLG is linked to malignant colon neoplasm.